• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再生障碍性贫血和特发性血小板减少性紫癜患者中血小板和巨核细胞对血清血小板生成素水平的调节

Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura.

作者信息

Ichikawa N, Ishida F, Shimodaira S, Tahara T, Kato T, Kitano K

机构信息

Second Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.

出版信息

Thromb Haemost. 1996 Aug;76(2):156-60.

PMID:8865522
Abstract

To clarify the regulatory mechanism of thrombopoietin (TPO, c-Mpl ligand) in chronic thrombocytopenic conditions, we determined TPO levels in the sera of patients with aplastic anaemia (AA; n = 26) and idiopathic thrombocytopenic purpura (ITP; n = 32) by an enzyme-linked immunosorbent assay. Despite a similarity in platelet counts, serum TPO levels in the AA group were markedly higher than those in the ITP group: 20.41 +/- 9.71 f mol/ml (mean +/- SD) and 1.66 +/- 0.55 f mol/ml, respectively, both of which were significantly elevated compared to normal subjects (n = 41; 1.22 +/- 0.37). In both groups, serum TPO level showed an inverse correlation with the platelet count. We determined the megakaryocyte volume using bone marrow clot section and found that it was markedly small in the AA group; while in the ITP group it was augmented with a correlation to serum TPO level. Our findings suggest that TPO levels may be regulated not only by platelets but also megakaryocytes in AA and ITP.

摘要

为阐明血小板生成素(TPO,c-Mpl配体)在慢性血小板减少症中的调节机制,我们采用酶联免疫吸附测定法测定了再生障碍性贫血(AA;n = 26)和特发性血小板减少性紫癜(ITP;n = 32)患者血清中的TPO水平。尽管两组患者的血小板计数相似,但AA组的血清TPO水平显著高于ITP组:分别为20.41±9.71 fmol/ml(平均值±标准差)和1.66±0.55 fmol/ml,与正常受试者(n = 41;1.22±0.37)相比均显著升高。在两组中,血清TPO水平与血小板计数呈负相关。我们使用骨髓凝块切片测定巨核细胞体积,发现AA组明显较小;而ITP组则增大,且与血清TPO水平相关。我们的研究结果表明,在AA和ITP中,TPO水平可能不仅受血小板调节,还受巨核细胞调节。

相似文献

1
Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura.再生障碍性贫血和特发性血小板减少性紫癜患者中血小板和巨核细胞对血清血小板生成素水平的调节
Thromb Haemost. 1996 Aug;76(2):156-60.
2
Plasma thrombopoietin levels in patients with aplastic anemia and idiopathic thrombocytopenic purpura.再生障碍性贫血和特发性血小板减少性紫癜患者的血浆血小板生成素水平
Chin Med J (Engl). 2002 Jul;115(7):983-6.
3
Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations.通过同时测定全血网织血小板和血清血小板生成素浓度评估血小板减少症中的血小板生成情况。
Thromb Haemost. 1998 Jun;79(6):1106-10.
4
Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura.无巨核细胞性血小板减少症患者的血清血小板生成素(TPO)水平远高于免疫性血小板减少性紫癜患者。
Thromb Haemost. 1996 Nov;76(5):675-8.
5
[The relativity study of thrombopoietin and chronic idiopathic thrombocytopenic purpura].[血小板生成素与慢性特发性血小板减少性紫癜的相关性研究]
Zhonghua Xue Ye Xue Za Zhi. 2001 Sep;22(9):473-5.
6
Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia.网织血小板、血浆糖萼蛋白及血小板生成素水平检测对鉴别高破坏性与发育不全性血小板减少症的诊断价值
Am J Clin Pathol. 2001 May;115(5):656-64. doi: 10.1309/RAW2-0LQW-8YTX-941V.
7
The diagnostic value of thrombopoietin level measurements in thrombocytopenia.血小板生成素水平检测在血小板减少症中的诊断价值。
Thromb Haemost. 1998 Jun;79(6):1101-5.
8
Serum thrombopoietin level in various hematological diseases.各种血液系统疾病中的血清血小板生成素水平。
Stem Cells. 1996 Sep;14(5):558-65. doi: 10.1002/stem.140558.
9
Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation.血栓性血小板减少性紫癜、特发性血小板减少性紫癜或弥散性血管内凝血患者血清血小板生成素水平升高。
Blood Coagul Fibrinolysis. 1997 Sep;8(6):345-9. doi: 10.1097/00001721-199709000-00004.
10
Plasma thrombopoietin levels in thrombocytopenic states: implication for a regulatory role of bone marrow megakaryocytes.血小板减少状态下的血浆血小板生成素水平:对骨髓巨核细胞调节作用的意义。
Br J Haematol. 1998 Jun;101(3):420-4. doi: 10.1046/j.1365-2141.1998.00747.x.

引用本文的文献

1
Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.成人原发性免疫性血小板减少症诊断参考指南,2023 年版。
Int J Hematol. 2024 Jan;119(1):1-13. doi: 10.1007/s12185-023-03672-1. Epub 2023 Nov 13.
2
Defective binding of ETS1 and STAT4 due to a mutation in the promoter region of as a novel mechanism of congenital amegakaryocytic thrombocytopenia.ETS1 和 STAT4 因启动子区域突变导致结合缺陷,这是先天性巨核细胞血小板减少症的一种新机制。
Haematologica. 2023 May 1;108(5):1385-1393. doi: 10.3324/haematol.2022.281392.
3
A cross-sectional study on thrombopoietin levels in immune thrombocytopenia and its correlation with platelet count, megakaryocytes, and treatment response.
免疫性血小板减少症患者血小板生成素水平及其与血小板计数、巨核细胞和治疗反应相关性的横断面研究
Asian J Transfus Sci. 2022 Jan-Jun;16(1):95-98. doi: 10.4103/ajts.AJTS_65_17. Epub 2022 May 26.
4
Thrombopoietin receptor agonist for treatment of immune thrombocytopenia in pregnancy: a narrative review.用于治疗妊娠期免疫性血小板减少症的血小板生成素受体激动剂:一项叙述性综述。
Ther Adv Hematol. 2021 Mar 19;12:20406207211001139. doi: 10.1177/20406207211001139. eCollection 2021.
5
C-Cbl regulates c-MPL receptor trafficking and its internalization.C-Cbl 调节 c-MPL 受体的运输及其内化。
J Cell Mol Med. 2020 Nov;24(21):12491-12503. doi: 10.1111/jcmm.15785. Epub 2020 Sep 20.
6
The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin.血小板生成素受体:配体、突变、激动剂及突变型钙网蛋白介导的转运与激活的结构基础
Front Endocrinol (Lausanne). 2017 Mar 31;8:59. doi: 10.3389/fendo.2017.00059. eCollection 2017.
7
Platelet clearance by the hepatic Ashwell-Morrell receptor: mechanisms and biological significance.肝脏阿什韦尔-莫雷尔受体介导的血小板清除:机制与生物学意义
Thromb Res. 2016 May;141 Suppl 2(Suppl 2):S68-72. doi: 10.1016/S0049-3848(16)30370-X.
8
Regulating billions of blood platelets: glycans and beyond.调控数十亿计的血小板:聚糖及其他
Blood. 2015 Oct 15;126(16):1877-84. doi: 10.1182/blood-2015-01-569129. Epub 2015 Sep 1.
9
Novel mechanisms of platelet clearance and thrombopoietin regulation.血小板清除和血小板生成素调节的新机制。
Curr Opin Hematol. 2015 Sep;22(5):445-51. doi: 10.1097/MOH.0000000000000170.
10
The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling.阿什韦尔-莫雷尔受体通过JAK2-STAT3信号通路调节肝脏血小板生成素的产生。
Nat Med. 2015 Jan;21(1):47-54. doi: 10.1038/nm.3770. Epub 2014 Dec 8.